drug · gene
patient view →lisocabtagene maraleucel
Phase 2updated 2mo agoby Bristol-Myers Squibb Co🔗 ChEMBL
Phase 2community read0 votes
Gene drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 8 investigational indications.
indications
indications
DLBCL
targets
B-lymphocyte antigen CD19
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that